MedAvail Holdings Inc logo

MDVL

MedAvail Holdings Inc

$1.04

Earnings Summary

Revenue
$9.11Mn
Net Profits
$-13.02Mn
Net Profit Margins
-142.88%

Highlights

Revenue:

MedAvail Holdings Inc’s revenue jumped 126.32% since last year same period to $9.11Mn in the Q1 2022. On a quarterly growth basis, MedAvail Holdings Inc has generated 25.19% jump in its revenue since last 3-months.

Net Profits:

MedAvail Holdings Inc’s net profit fell -37.77% since last year same period to $-13.02Mn in the Q1 2022. On a quarterly growth basis, MedAvail Holdings Inc has generated -3.14% fall in its net profits since last 3-months.

Net Profit Margins:

MedAvail Holdings Inc’s net profit margin jumped 39.13% since last year same period to -142.88% in the Q1 2022. On a quarterly growth basis, MedAvail Holdings Inc has generated 17.62% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the MedAvail Holdings Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.36
EPS Estimate Current Year
-0.36

Highlights

EPS Estimate Current Quarter:

MedAvail Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at -0.36 - a -2.86% fall from last quarter’s estimates.

EPS Estimate Current Year:

MedAvail Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.36.

Key Ratios

Key ratios of the MedAvail Holdings Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.4
Return on Assets (ROA)
-0.52
Return on Equity (ROE)
-1.3
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

MedAvail Holdings Inc’s earning per share (EPS) fell -37.93% since last year same period to -0.4 in the Q1 2022. This indicates that the MedAvail Holdings Inc has generated -37.93% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. MedAvail Holdings Inc’s return on assets (ROA) stands at -0.52.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. MedAvail Holdings Inc’s return on equity (ROE) stands at -1.3.

Dividend Per Share (DPS):

MedAvail Holdings Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-13
-0.36
-0.4
-11.11%

Company Information

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes.

Organisation
MedAvail Holdings Inc
Headquarters
Cedar Knolls, New Jersey, US
Employees
2.02K
Industry
Medical Specialties
CEO
Joseph Mannello